Leidos
LDOS
$113.58
-0.89%
Leidos Holdings, Inc. is a major technology, engineering, and science company providing services and solutions primarily to U.S. government agencies in defense, intelligence, civil, and health sectors. It operates as a leading government IT services contractor, distinguished by its scale and deep integration into critical national security and civilian infrastructure. The current investor narrative is dominated by a stark contrast between record profitability and significant stock price weakness, driven by a recent revenue miss, cautious guidance overshadowed by government budget uncertainty, and emerging competitive threats from private-sector innovators in autonomous defense systems.…
LDOS
Leidos
$113.58
Related headlines
Investment Opinion: Should I buy LDOS Today?
Rating & Thesis: Hold. Leidos presents a high-risk, potentially high-reward situation where severe technical and sentiment damage contrasts with a cheap valuation and strong cash flow, but the fundamental deterioration requires a 'wait-and-see' approach before committing capital. The recent analyst downgrade to Hold and wide EPS estimate dispersion support this cautious stance.
Supporting Evidence: The stock trades at a deeply discounted forward P/E of 9.29x, well below its trailing P/E of 16.69x, implying the market expects a sharp earnings rebound. However, this optimism is challenged by declining revenue (-3.62% YoY) and contracting gross margins (down 240 bps QoQ). Positively, robust TTM free cash flow of $1.625B and a solid current ratio of 1.70 provide a financial cushion. The stock's price near its 52-week low suggests significant pessimism is already priced in.
Risks & Conditions: The two biggest risks are further revenue deceleration and sustained margin pressure from competitive disruption. This Hold rating would upgrade to a Buy if the company demonstrates a return to sequential revenue growth and stabilizes gross margins above 17% in the next quarter. It would downgrade to a Sell if revenue declines accelerate beyond -5% YoY or if the forward P/E expands due to further earnings estimate cuts. Relative to its own history and the challenged outlook, the stock appears fairly to slightly undervalued, but not enough to overcome the clear negative momentum.
Sign up to view all
LDOS 12-Month Price Forecast
The investment case for LDOS is balanced on a knife's edge between deep value and value trap. The extreme valuation discount (forward P/E 9.29x) and robust cash flow are powerful bullish anchors, but they are directly opposed by deteriorating fundamentals (revenue decline, margin compression) and a clear technical downtrend. The neutral stance reflects this high uncertainty; the path of the next 1-2 quarterly reports will be decisive. The stance would turn bullish on evidence of fundamental stabilization (revenue growth, margin hold), and would turn bearish if the current negative trends accelerate, rendering the cheap valuation meaningless.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Leidos's 12-month outlook, with a consensus price target around $147.65 and implied upside of +30.0% versus the current price.
Average Target
$147.65
9 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
9
covering this stock
Price Range
$91 - $148
Analyst target range
The stock is covered by 9 analysts, and recent institutional rating actions show a pattern of downgrades and cautious holds, such as Stifel moving from Buy to Hold in January 2026, which aligns with the stock's subsequent steep decline. The average analyst target price or a clear consensus recommendation is not explicitly provided in the data, indicating that while there is coverage, forward estimates may be in flux following the weak outlook; the estimated EPS range for the next period is wide, from $12.78 to $15.70, signaling high uncertainty among analysts about the company's near-term earnings power. The wide dispersion in EPS estimates and the recent downgrade activity point to low conviction and high uncertainty in the analyst community, which typically correlates with elevated stock volatility and challenges in near-term price discovery as the market awaits clearer fundamental direction.
Bulls vs Bears: LDOS Investment Factors
The evidence currently favors the bear case, given the concrete deterioration in fundamental metrics—specifically, the -3.62% YoY revenue decline and the 240 basis point quarterly gross margin compression—which have triggered a severe technical breakdown. The primary tension in the investment debate is whether the stock's extreme valuation discount (forward P/E of 9.29x) accurately prices in a permanent slowdown and competitive disruption, or if it represents an overreaction to cyclical government budget uncertainty and temporary margin issues. The resolution hinges on the next quarter's revenue growth and margin trajectory; a stabilization would support the bull case for a re-rating, while further deterioration would validate the bearish narrative of structural decline.
Bullish
- Strong Free Cash Flow Generation: The company generated $1.625 billion in trailing twelve-month free cash flow, providing significant financial flexibility. This robust cash flow supports the dividend (0.87% yield), debt service, and potential share repurchases, offering a margin of safety.
- Compelling Forward Valuation: The stock trades at a forward P/E of 9.29x, a steep discount to its trailing P/E of 16.69x, indicating the market expects a sharp earnings recovery. This forward multiple is exceptionally low for a profitable government contractor, suggesting significant upside if earnings stabilize.
- Solid Balance Sheet and Liquidity: A current ratio of 1.70 and a debt-to-equity ratio of 1.21 indicate a manageable capital structure with ample liquidity. This financial stability is crucial for navigating government budget cycles and funding operations during a revenue slowdown.
- Technical Oversold Condition: The stock is trading at $122.16, just 0.6% above its 52-week low of $121.20, following a 35.61% decline over six months. This extreme technical weakness suggests most negative news may be priced in, creating a potential entry point for value investors.
Bearish
- Revenue Contraction and Guidance Miss: Q4 2025 revenue of $4.207B declined 3.62% YoY and fell sequentially from Q3's $4.469B. This deceleration, coupled with cautious guidance that overshadowed record profits, is the primary driver of the stock's 35% six-month decline.
- Severe Margin Compression: Gross margin collapsed to 16.0% in Q4 2025 from 18.4% in Q3 2025, indicating significant cost pressure or unfavorable contract mix. This erosion in profitability directly impacts earnings quality and future cash flow generation.
- Disruptive Competitive Threat: Recent news highlights emerging competition from private-sector innovators like Saronic in autonomous defense systems. This threatens Leidos's core government IT and engineering services model and could pressure long-term growth and margins.
- Persistent Technical Downtrend: The stock is in a severe downtrend, down 29.74% over three months with no signs of reversal. Its beta of 0.515 indicates it has underperformed the market (SPY up 12% over 3 months) by over 41 percentage points, showing deep, sustained institutional selling.
LDOS Technical Analysis
The stock is in a pronounced and sustained downtrend, having declined 17.47% over the past year and a severe 35.61% over the last six months. With a current price of $122.16, it is trading near the very bottom of its 52-week range of $121.20 to $205.77, positioning it at just 0.6% above the annual low, which suggests extreme technical weakness and potential capitulation, though it also flags a high-risk 'falling knife' scenario. Recent momentum shows no signs of reversal, with the stock down 29.74% over three months and a further 1.62% over the past month, indicating persistent selling pressure that aligns with the longer-term bearish trend. The stock's beta of 0.515 indicates it has been significantly less volatile than the broader market during this decline, which is unusual for a downtrend of this magnitude and may suggest a lack of speculative interest or a steady, institutional unwind. Key technical levels are clear, with immediate support at the 52-week low of $121.20; a decisive break below this level could trigger another leg down, while any recovery would first need to contend with overhead resistance building from the recent breakdowns, with the 52-week high of $205.77 representing a distant target requiring a fundamental catalyst shift.
Beta
0.52
0.52x market volatility
Max Drawdown
-43.1%
Largest decline past year
52-Week Range
$113-$206
Price range past year
Annual Return
-23.4%
Cumulative gain past year
| Period | LDOS Return | S&P 500 |
|---|---|---|
| 1m | -8.2% | +1.5% |
| 3m | -31.9% | +13.4% |
| 6m | -37.3% | +10.9% |
| 1y | -23.4% | +24.5% |
| ytd | -38.1% | +10.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LDOS Fundamental Analysis
Revenue growth has stalled and turned negative, with the most recent quarterly revenue of $4.207 billion representing a 3.62% year-over-year decline, and a sequential drop from the prior quarter's $4.469 billion, indicating a concerning deceleration in the business trajectory. The company remains profitable with net income of $335 million for the quarter, but profitability metrics are under pressure, as evidenced by a gross margin of 16.0%, which is down from 18.4% in the prior quarter and below the trailing net margin of 8.48%, suggesting cost inflation or mix issues are compressing earnings quality. Financially, the balance sheet shows moderate leverage with a debt-to-equity ratio of 1.21, but strong liquidity is provided by a current ratio of 1.70 and robust free cash flow generation, with TTM free cash flow of $1.625 billion offering ample capacity to service debt, pay its dividend (yield 0.87%), and navigate the current cyclical slowdown.
Quarterly Revenue
$4.2B
2026-01
Revenue YoY Growth
-0.03%
YoY Comparison
Gross Margin
+0.16%
Latest Quarter
Free Cash Flow
$1.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LDOS Overvalued?
Given positive net income, the primary valuation metric is the P/E ratio. The trailing P/E stands at 16.69x, while the forward P/E is significantly lower at 9.29x, indicating the market expects a substantial recovery in earnings over the next year, though this gap also reflects the depressed current price following the stock's steep decline. Compared to its own historical range, the current trailing P/E of 16.69x sits well below the higher end of its historical band seen in recent quarters (e.g., 18.13x in Q4 2025) and is near the lower end observed over the past few years, suggesting the stock is pricing in a pessimistic scenario relative to its own history. The stock trades at a Price/Sales ratio of 1.41x and an EV/Sales of 1.26x, which are modest multiples for a government services contractor, implying the market is assigning little premium for growth and is focused on the near-term revenue headwinds and competitive risks highlighted in recent news.
PE
16.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -8x~22x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Leidos faces significant financial risks from its recent revenue contraction (-3.62% YoY) and sharp margin compression, with gross margin falling from 18.4% to 16.0% in one quarter. This raises concerns about cost inflation and contract profitability. While the balance sheet is stable (Debt/Equity of 1.21), the company's earnings are highly sensitive to government spending cycles, and the recent guidance miss indicates visibility is low. Dependence on U.S. government agencies, while providing a baseline, creates concentration risk if budget priorities shift away from its service areas.
Market & Competitive Risks: The stock's valuation has compressed, but its forward P/E of 9.29x reflects deep skepticism, leaving it vulnerable to further multiple contraction if growth does not materialize. The emerging competitive threat from agile private-sector firms like Saronic in autonomous systems represents a disruptive, long-term risk to Leidos's traditional contracting model. Furthermore, the stock's low beta of 0.515 has not protected it during this sell-off, indicating company-specific, not macro, drivers are at play, which could lead to prolonged underperformance even in a rising market.
Worst-Case Scenario: The worst-case scenario involves a continuation of the current downtrend: government budget delays persist, competitive pressures intensify, and margins continue to erode, leading to consecutive earnings misses. This could trigger further analyst downgrades and a loss of investor confidence. Realistic downside could see the stock break its 52-week low of $121.20 and test levels implied by a forward P/E in the high single-digits on reduced earnings, suggesting a potential additional decline of 15-20% from the current price, translating to a target range near $100-$105.
FAQ
The key risks are, in order of severity: 1) Fundamental Deterioration Risk: Continued revenue decline and gross margin compression, as seen in the latest quarter (-3.62% YoY revenue, 16.0% gross margin). 2) Competitive Disruption Risk: Emerging threats from private-sector innovators like Saronic in autonomous systems, which could erode Leidos's long-term contract base. 3) Government Budget Risk: Revenue concentration with U.S. agencies makes the company vulnerable to political delays and shifting spending priorities. 4) Sentiment and Technical Risk: The stock is in a severe downtrend (down 35.61% in 6 months) with weak analyst sentiment, which can lead to further selling regardless of valuation.
Our 12-month outlook presents three scenarios with associated probabilities. The Base Case (50% probability) sees the stock trading between $135 and $155, as the company muddles through with flat growth and stabilized margins. The Bull Case (25% probability), requiring a fundamental turnaround, projects a range of $165 to $185. The Bear Case (25% probability), involving worsening fundamentals, forecasts a decline to $105-$125. The most likely scenario is the Base Case, which assumes the current negative trends do not accelerate but also do not meaningfully improve. The wide dispersion in analyst EPS estimates ($12.78 to $15.70) underscores the high uncertainty driving this forecast.
Based on traditional metrics, LDOS appears significantly undervalued. Its forward P/E of 9.29x is exceptionally low for a profitable company and represents a steep discount to its own trailing P/E of 16.69x. The Price/Sales ratio of 1.41x and EV/Sales of 1.26x are also modest. However, this discount reflects the market's expectation of deteriorating fundamentals. The valuation implies the market expects little to no growth and potentially further earnings contraction. Therefore, while statistically cheap, the stock may be fairly valued or even overvalued if the bearish scenario of sustained revenue and margin pressure plays out. It is a classic 'value trap' candidate until fundamentals stabilize.
LDOS is a high-risk, high-potential-reward stock that may be suitable for specific investors. At a forward P/E of 9.29x and trading just 0.6% above its 52-week low, it appears deeply undervalued relative to its cash flow and historical multiples. However, it is not a good buy for all investors. The significant revenue decline (-3.62% YoY) and margin compression are serious fundamental red flags. It could be a good buy for patient, contrarian value investors who believe the government budget and competitive threats are overstated, and who are willing to wait for a turnaround. The 25% probability assigned to the bull case with a target up to $185 suggests the potential reward is substantial, but the risk of further downside to $105 is equally real.
LDOS is unsuitable for short-term trading due to its high uncertainty, negative momentum, and low beta (0.515), which suggests it may not react to broad market moves. It is a speculative long-term investment for investors with a 2-3 year horizon who are betting on a business turnaround and valuation normalization. The company's strong free cash flow and dividend provide some income while waiting, but the primary thesis is capital appreciation from a re-rating. Given the need to see multiple quarters of stabilizing financials, a minimum holding period of 12-18 months is suggested to properly assess whether the turnaround is materializing.
